Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)

Clinical trial NCT07277764 · RECRUITING

Trial details

NCT number: NCT07277764
Sponsor: Jiangxi Provincial Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma (NPC)Recurrent Nasopharyngeal Neoplasms

Start date: 2025-10-10
Primary completion: 2027-12-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.